» Articles » PMID: 12104041

Curcumin Inhibits Telomerase Activity Through Human Telomerase Reverse Transcritpase in MCF-7 Breast Cancer Cell Line

Overview
Journal Cancer Lett
Specialty Oncology
Date 2002 Jul 10
PMID 12104041
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The inhibitory effect of curcumin, the yellow-colored pigment from turmeric, on telomerase activity was analyzed in human mammary epithelial (MCF-10A) and breast cancer (MCF-7) cells. Telomerase activity in MCF-7 cells is 6.9-fold higher than that of human mammary epithelial cells. In MCF-7 cells, telomerase activity decreased with increasing concentrations of curcumin, inhibiting about 93.4% activity at 100 microM concentration. The inhibition of telomerase activity in MCF-7 cells may be due to down-regulation of hTERT expression. Increasing concentrations of curcumin caused a steady decrease in the level of hTERT mRNA in MCF-7 cells whereas the level of hTER and c-myc mRNAs remained the same. Our results suggest that curcumin inhibits telomerase activity by down-regulating hTERT expression in breast cancer cells and this down-regulation is not through the c-myc pathway.

Citing Articles

Telomerase inhibition in breast cancer and breast cancer stem cells: a brief review.

Yildirim I, Biray Avci C Med Oncol. 2024; 42(1):14.

PMID: 39585534 DOI: 10.1007/s12032-024-02562-8.


Aging, Cancer, and Inflammation: The Telomerase Connection.

Boccardi V, Marano L Int J Mol Sci. 2024; 25(15).

PMID: 39126110 PMC: 11313618. DOI: 10.3390/ijms25158542.


Curcumin in Cancer Prevention: Insights from Clinical Trials and Strategies to Enhance Bioavailability.

Alam S, Lee J, Sahebkar A Curr Pharm Des. 2024; 30(23):1838-1851.

PMID: 38808709 DOI: 10.2174/0113816128303514240517054617.


Phytocompounds-based therapeutic approach: Investigating curcumin and green tea extracts on MCF-7 breast cancer cell line.

Fawzy R, Abdel-Aziz A, Bassiouny K, Fayed A J Genet Eng Biotechnol. 2024; 22(1):100339.

PMID: 38494270 PMC: 10980874. DOI: 10.1016/j.jgeb.2023.100339.


Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA).

Ali J, Walter M Cancer Cell Int. 2023; 23(1):197.

PMID: 37679807 PMC: 10483736. DOI: 10.1186/s12935-023-03041-2.